nodes	percent_of_prediction	percent_of_DWPC	metapath
Exemestane—Thromboembolism—Sorafenib—liver cancer	0.0318	0.0386	CcSEcCtD
Exemestane—Hoarseness—Sorafenib—liver cancer	0.023	0.0279	CcSEcCtD
Exemestane—Embolism venous—Sorafenib—liver cancer	0.02	0.0243	CcSEcCtD
Exemestane—Embolism—Sorafenib—liver cancer	0.0158	0.0191	CcSEcCtD
Exemestane—Lymphoedema—Epirubicin—liver cancer	0.0153	0.0186	CcSEcCtD
Exemestane—Lymphoedema—Doxorubicin—liver cancer	0.0142	0.0172	CcSEcCtD
Exemestane—Leg edema—Epirubicin—liver cancer	0.0139	0.0168	CcSEcCtD
Exemestane—Leg edema—Doxorubicin—liver cancer	0.0128	0.0156	CcSEcCtD
Exemestane—Myocardial ischaemia—Sorafenib—liver cancer	0.0126	0.0153	CcSEcCtD
Exemestane—Dysphonia—Sorafenib—liver cancer	0.0123	0.0149	CcSEcCtD
Exemestane—Neoplasm malignant—Sorafenib—liver cancer	0.0118	0.0144	CcSEcCtD
Exemestane—Thromboembolism—Epirubicin—liver cancer	0.0118	0.0143	CcSEcCtD
Exemestane—Multi-organ failure—Epirubicin—liver cancer	0.0115	0.0139	CcSEcCtD
Exemestane—Bone disorder—Sorafenib—liver cancer	0.0112	0.0136	CcSEcCtD
Exemestane—Thromboembolism—Doxorubicin—liver cancer	0.0109	0.0132	CcSEcCtD
Exemestane—Multi-organ failure—Doxorubicin—liver cancer	0.0106	0.0129	CcSEcCtD
Exemestane—Influenza like illness—Sorafenib—liver cancer	0.00982	0.0119	CcSEcCtD
Exemestane—CYP3A4—Felbamate Metabolism—CYP2E1—liver cancer	0.00956	0.0619	CbGpPWpGaD
Exemestane—Neuropathy—Sorafenib—liver cancer	0.0095	0.0115	CcSEcCtD
Exemestane—Opportunistic infection—Epirubicin—liver cancer	0.00928	0.0113	CcSEcCtD
Exemestane—Neoplasm—Sorafenib—liver cancer	0.00915	0.0111	CcSEcCtD
Exemestane—Opportunistic infection—Doxorubicin—liver cancer	0.00859	0.0104	CcSEcCtD
Exemestane—CYP19A1—Endogenous sterols—NR1H4—liver cancer	0.00852	0.0552	CbGpPWpGaD
Exemestane—Cardiac failure—Sorafenib—liver cancer	0.00752	0.00913	CcSEcCtD
Exemestane—Embolism venous—Epirubicin—liver cancer	0.00741	0.00899	CcSEcCtD
Exemestane—Pain in extremity—Sorafenib—liver cancer	0.00734	0.00891	CcSEcCtD
Exemestane—Embolism venous—Doxorubicin—liver cancer	0.00686	0.00832	CcSEcCtD
Exemestane—Gastric ulcer—Epirubicin—liver cancer	0.00643	0.00781	CcSEcCtD
Exemestane—Polyp—Epirubicin—liver cancer	0.00615	0.00746	CcSEcCtD
Exemestane—Gastric ulcer—Doxorubicin—liver cancer	0.00595	0.00722	CcSEcCtD
Exemestane—Embolism—Epirubicin—liver cancer	0.00582	0.00707	CcSEcCtD
Exemestane—CYP3A4—Liver X Receptor Pathway—SCD—liver cancer	0.00575	0.0372	CbGpPWpGaD
Exemestane—Polyp—Doxorubicin—liver cancer	0.00569	0.0069	CcSEcCtD
Exemestane—Acute coronary syndrome—Sorafenib—liver cancer	0.00558	0.00677	CcSEcCtD
Exemestane—Myocardial infarction—Sorafenib—liver cancer	0.00555	0.00673	CcSEcCtD
Exemestane—Neuropathy peripheral—Sorafenib—liver cancer	0.00555	0.00673	CcSEcCtD
Exemestane—Embolism—Doxorubicin—liver cancer	0.00539	0.00654	CcSEcCtD
Exemestane—Hepatobiliary disease—Sorafenib—liver cancer	0.00535	0.0065	CcSEcCtD
Exemestane—Haemoglobin—Sorafenib—liver cancer	0.00511	0.0062	CcSEcCtD
Exemestane—Haemorrhage—Sorafenib—liver cancer	0.00508	0.00617	CcSEcCtD
Exemestane—Vaginal haemorrhage—Epirubicin—liver cancer	0.00505	0.00613	CcSEcCtD
Exemestane—Erythema multiforme—Sorafenib—liver cancer	0.0048	0.00583	CcSEcCtD
Exemestane—Cardiac disorder—Sorafenib—liver cancer	0.00471	0.00572	CcSEcCtD
Exemestane—Vaginal haemorrhage—Doxorubicin—liver cancer	0.00467	0.00567	CcSEcCtD
Exemestane—Immune system disorder—Sorafenib—liver cancer	0.00459	0.00557	CcSEcCtD
Exemestane—Dysphonia—Epirubicin—liver cancer	0.00454	0.00551	CcSEcCtD
Exemestane—Estropipate—ESR1—liver cancer	0.00453	0.21	CrCbGaD
Exemestane—Alopecia—Sorafenib—liver cancer	0.00449	0.00545	CcSEcCtD
Exemestane—Mental disorder—Sorafenib—liver cancer	0.00445	0.0054	CcSEcCtD
Exemestane—Neoplasm malignant—Epirubicin—liver cancer	0.00438	0.00531	CcSEcCtD
Exemestane—Cardiovascular disorder—Epirubicin—liver cancer	0.00426	0.00516	CcSEcCtD
Exemestane—Muscle spasms—Sorafenib—liver cancer	0.00425	0.00516	CcSEcCtD
Exemestane—Dysphonia—Doxorubicin—liver cancer	0.0042	0.0051	CcSEcCtD
Exemestane—Bone disorder—Epirubicin—liver cancer	0.00414	0.00502	CcSEcCtD
Exemestane—Viral infection—Epirubicin—liver cancer	0.00414	0.00502	CcSEcCtD
Exemestane—Neoplasm malignant—Doxorubicin—liver cancer	0.00405	0.00492	CcSEcCtD
Exemestane—Leukopenia—Sorafenib—liver cancer	0.00396	0.0048	CcSEcCtD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00396	0.0256	CbGpPWpGaD
Exemestane—Cardiovascular disorder—Doxorubicin—liver cancer	0.00394	0.00478	CcSEcCtD
Exemestane—Bone pain—Epirubicin—liver cancer	0.0039	0.00474	CcSEcCtD
Exemestane—Cough—Sorafenib—liver cancer	0.00386	0.00468	CcSEcCtD
Exemestane—Viral infection—Doxorubicin—liver cancer	0.00383	0.00465	CcSEcCtD
Exemestane—Bone disorder—Doxorubicin—liver cancer	0.00383	0.00465	CcSEcCtD
Exemestane—Hypertension—Sorafenib—liver cancer	0.00382	0.00463	CcSEcCtD
Exemestane—Musculoskeletal pain—Epirubicin—liver cancer	0.00378	0.00459	CcSEcCtD
Exemestane—Arthralgia—Sorafenib—liver cancer	0.00377	0.00457	CcSEcCtD
Exemestane—Myalgia—Sorafenib—liver cancer	0.00377	0.00457	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00374	0.00454	CcSEcCtD
Exemestane—Pulmonary embolism—Epirubicin—liver cancer	0.00374	0.00454	CcSEcCtD
Exemestane—Influenza like illness—Epirubicin—liver cancer	0.00363	0.00441	CcSEcCtD
Exemestane—Bone pain—Doxorubicin—liver cancer	0.00361	0.00438	CcSEcCtD
Exemestane—Infection—Sorafenib—liver cancer	0.00359	0.00435	CcSEcCtD
Exemestane—Nervous system disorder—Sorafenib—liver cancer	0.00354	0.0043	CcSEcCtD
Exemestane—Thrombocytopenia—Sorafenib—liver cancer	0.00353	0.00429	CcSEcCtD
Exemestane—Neuropathy—Epirubicin—liver cancer	0.00351	0.00426	CcSEcCtD
Exemestane—Skin disorder—Sorafenib—liver cancer	0.00351	0.00425	CcSEcCtD
Exemestane—Musculoskeletal pain—Doxorubicin—liver cancer	0.0035	0.00425	CcSEcCtD
Exemestane—Pulmonary embolism—Doxorubicin—liver cancer	0.00346	0.0042	CcSEcCtD
Exemestane—Anorexia—Sorafenib—liver cancer	0.00344	0.00418	CcSEcCtD
Exemestane—Neoplasm—Epirubicin—liver cancer	0.00338	0.0041	CcSEcCtD
Exemestane—Influenza like illness—Doxorubicin—liver cancer	0.00336	0.00408	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00329	0.00399	CcSEcCtD
Exemestane—Neuropathy—Doxorubicin—liver cancer	0.00325	0.00394	CcSEcCtD
Exemestane—Dyspnoea—Sorafenib—liver cancer	0.00322	0.00391	CcSEcCtD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00321	0.0208	CbGpPWpGaD
Exemestane—Dyspepsia—Sorafenib—liver cancer	0.00318	0.00386	CcSEcCtD
Exemestane—CYP3A4—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.00317	0.0205	CbGpPWpGaD
Exemestane—Decreased appetite—Sorafenib—liver cancer	0.00314	0.00381	CcSEcCtD
Exemestane—Neoplasm—Doxorubicin—liver cancer	0.00313	0.0038	CcSEcCtD
Exemestane—Gastrointestinal disorder—Sorafenib—liver cancer	0.00312	0.00378	CcSEcCtD
Exemestane—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.00311	0.0202	CbGpPWpGaD
Exemestane—Fatigue—Sorafenib—liver cancer	0.00311	0.00378	CcSEcCtD
Exemestane—Pain—Sorafenib—liver cancer	0.00309	0.00375	CcSEcCtD
Exemestane—Constipation—Sorafenib—liver cancer	0.00309	0.00375	CcSEcCtD
Exemestane—Gastrointestinal pain—Sorafenib—liver cancer	0.00295	0.00358	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—UGDH—liver cancer	0.00292	0.0189	CbGpPWpGaD
Exemestane—Hot flush—Epirubicin—liver cancer	0.0029	0.00352	CcSEcCtD
Exemestane—CYP3A4—Farnesoid X Receptor  Pathway—NR1H4—liver cancer	0.0029	0.0188	CbGpPWpGaD
Exemestane—Increased appetite—Epirubicin—liver cancer	0.00289	0.00351	CcSEcCtD
Exemestane—Menopausal symptoms—Epirubicin—liver cancer	0.00288	0.00349	CcSEcCtD
Exemestane—Urticaria—Sorafenib—liver cancer	0.00287	0.00348	CcSEcCtD
Exemestane—Abdominal pain—Sorafenib—liver cancer	0.00285	0.00346	CcSEcCtD
Exemestane—Body temperature increased—Sorafenib—liver cancer	0.00285	0.00346	CcSEcCtD
Exemestane—Conjugated Estrogens—ESR1—liver cancer	0.00283	0.131	CrCbGaD
Exemestane—Estrone—ESR1—liver cancer	0.00282	0.131	CrCbGaD
Exemestane—Cardiac failure—Epirubicin—liver cancer	0.00278	0.00337	CcSEcCtD
Exemestane—Cerebrovascular accident—Epirubicin—liver cancer	0.00277	0.00336	CcSEcCtD
Exemestane—Osteoarthritis—Epirubicin—liver cancer	0.00271	0.00329	CcSEcCtD
Exemestane—Pain in extremity—Epirubicin—liver cancer	0.00271	0.00329	CcSEcCtD
Exemestane—Hot flush—Doxorubicin—liver cancer	0.00268	0.00326	CcSEcCtD
Exemestane—Increased appetite—Doxorubicin—liver cancer	0.00267	0.00324	CcSEcCtD
Exemestane—CYP19A1—Tryptophan metabolism—CYP2E1—liver cancer	0.00267	0.0173	CbGpPWpGaD
Exemestane—Menopausal symptoms—Doxorubicin—liver cancer	0.00266	0.00323	CcSEcCtD
Exemestane—CYP3A4—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.00266	0.0172	CbGpPWpGaD
Exemestane—Hypersensitivity—Sorafenib—liver cancer	0.00266	0.00323	CcSEcCtD
Exemestane—Asthenia—Sorafenib—liver cancer	0.00259	0.00314	CcSEcCtD
Exemestane—Cardiac failure—Doxorubicin—liver cancer	0.00257	0.00312	CcSEcCtD
Exemestane—Cerebrovascular accident—Doxorubicin—liver cancer	0.00256	0.00311	CcSEcCtD
Exemestane—CYP3A4—Estrogen metabolism—GSTA1—liver cancer	0.00256	0.0166	CbGpPWpGaD
Exemestane—Pruritus—Sorafenib—liver cancer	0.00255	0.0031	CcSEcCtD
Exemestane—Pain in extremity—Doxorubicin—liver cancer	0.00251	0.00305	CcSEcCtD
Exemestane—Osteoarthritis—Doxorubicin—liver cancer	0.00251	0.00305	CcSEcCtD
Exemestane—CYP19A1—FSH signaling pathway—MAPK14—liver cancer	0.00248	0.016	CbGpPWpGaD
Exemestane—Diarrhoea—Sorafenib—liver cancer	0.00247	0.003	CcSEcCtD
Exemestane—Dizziness—Sorafenib—liver cancer	0.00239	0.0029	CcSEcCtD
Exemestane—Vomiting—Sorafenib—liver cancer	0.00229	0.00278	CcSEcCtD
Exemestane—Angina pectoris—Epirubicin—liver cancer	0.00228	0.00277	CcSEcCtD
Exemestane—Estrone—CYP2E1—liver cancer	0.00228	0.106	CrCbGaD
Exemestane—Rash—Sorafenib—liver cancer	0.00228	0.00276	CcSEcCtD
Exemestane—Dermatitis—Sorafenib—liver cancer	0.00227	0.00276	CcSEcCtD
Exemestane—Headache—Sorafenib—liver cancer	0.00226	0.00274	CcSEcCtD
Exemestane—Bronchitis—Epirubicin—liver cancer	0.00226	0.00274	CcSEcCtD
Exemestane—Estrone—CYP1A1—liver cancer	0.00225	0.105	CrCbGaD
Exemestane—Upper respiratory tract infection—Epirubicin—liver cancer	0.00218	0.00265	CcSEcCtD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00216	0.014	CbGpPWpGaD
Exemestane—Nausea—Sorafenib—liver cancer	0.00214	0.0026	CcSEcCtD
Exemestane—Weight increased—Epirubicin—liver cancer	0.00213	0.00259	CcSEcCtD
Exemestane—CYP19A1—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00213	0.0138	CbGpPWpGaD
Exemestane—Angina pectoris—Doxorubicin—liver cancer	0.00211	0.00257	CcSEcCtD
Exemestane—Bronchitis—Doxorubicin—liver cancer	0.00209	0.00253	CcSEcCtD
Exemestane—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.00206	0.0134	CbGpPWpGaD
Exemestane—Neuropathy peripheral—Epirubicin—liver cancer	0.00205	0.00249	CcSEcCtD
Exemestane—Urinary tract infection—Epirubicin—liver cancer	0.00203	0.00247	CcSEcCtD
Exemestane—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00202	0.00245	CcSEcCtD
Exemestane—Estropipate—ALB—liver cancer	0.00202	0.0937	CrCbGaD
Exemestane—Sweating—Epirubicin—liver cancer	0.00201	0.00243	CcSEcCtD
Exemestane—Hepatobiliary disease—Epirubicin—liver cancer	0.00198	0.0024	CcSEcCtD
Exemestane—Weight increased—Doxorubicin—liver cancer	0.00198	0.0024	CcSEcCtD
Exemestane—Sinusitis—Epirubicin—liver cancer	0.00196	0.00238	CcSEcCtD
Exemestane—CYP19A1—Tryptophan metabolism—CYP1A1—liver cancer	0.00192	0.0124	CbGpPWpGaD
Exemestane—Neuropathy peripheral—Doxorubicin—liver cancer	0.0019	0.0023	CcSEcCtD
Exemestane—Haemoglobin—Epirubicin—liver cancer	0.00189	0.00229	CcSEcCtD
Exemestane—Rhinitis—Epirubicin—liver cancer	0.00188	0.00228	CcSEcCtD
Exemestane—Urinary tract infection—Doxorubicin—liver cancer	0.00188	0.00228	CcSEcCtD
Exemestane—Hepatitis—Epirubicin—liver cancer	0.00188	0.00228	CcSEcCtD
Exemestane—Haemorrhage—Epirubicin—liver cancer	0.00188	0.00228	CcSEcCtD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.00188	0.0122	CbGpPWpGaD
Exemestane—Hypoaesthesia—Epirubicin—liver cancer	0.00187	0.00227	CcSEcCtD
Exemestane—Pharyngitis—Epirubicin—liver cancer	0.00186	0.00226	CcSEcCtD
Exemestane—Sweating—Doxorubicin—liver cancer	0.00186	0.00225	CcSEcCtD
Exemestane—Oedema peripheral—Epirubicin—liver cancer	0.00185	0.00224	CcSEcCtD
Exemestane—Hepatobiliary disease—Doxorubicin—liver cancer	0.00183	0.00222	CcSEcCtD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.00182	0.0118	CbGpPWpGaD
Exemestane—Sinusitis—Doxorubicin—liver cancer	0.00182	0.0022	CcSEcCtD
Exemestane—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.00181	0.0117	CbGpPWpGaD
Exemestane—Visual impairment—Epirubicin—liver cancer	0.00181	0.0022	CcSEcCtD
Exemestane—CYP19A1—FSH signaling pathway—RAF1—liver cancer	0.0018	0.0117	CbGpPWpGaD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00179	0.0116	CbGpPWpGaD
Exemestane—Erythema multiforme—Epirubicin—liver cancer	0.00178	0.00215	CcSEcCtD
Exemestane—CYP19A1—FSH signaling pathway—MTOR—liver cancer	0.00176	0.0114	CbGpPWpGaD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00175	0.0113	CbGpPWpGaD
Exemestane—Haemoglobin—Doxorubicin—liver cancer	0.00175	0.00212	CcSEcCtD
Exemestane—Cardiac disorder—Epirubicin—liver cancer	0.00174	0.00211	CcSEcCtD
Exemestane—Rhinitis—Doxorubicin—liver cancer	0.00174	0.00211	CcSEcCtD
Exemestane—Haemorrhage—Doxorubicin—liver cancer	0.00174	0.00211	CcSEcCtD
Exemestane—Hepatitis—Doxorubicin—liver cancer	0.00174	0.00211	CcSEcCtD
Exemestane—Hypoaesthesia—Doxorubicin—liver cancer	0.00173	0.0021	CcSEcCtD
Exemestane—Pharyngitis—Doxorubicin—liver cancer	0.00172	0.00209	CcSEcCtD
Exemestane—Oedema peripheral—Doxorubicin—liver cancer	0.00171	0.00208	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—NR1H4—liver cancer	0.0017	0.011	CbGpPWpGaD
Exemestane—Immune system disorder—Epirubicin—liver cancer	0.0017	0.00206	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—GSTA3—liver cancer	0.00168	0.0108	CbGpPWpGaD
Exemestane—Visual impairment—Doxorubicin—liver cancer	0.00167	0.00203	CcSEcCtD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.00167	0.0108	CbGpPWpGaD
Exemestane—Alopecia—Epirubicin—liver cancer	0.00166	0.00201	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—GSTA3—liver cancer	0.00165	0.0107	CbGpPWpGaD
Exemestane—Mental disorder—Epirubicin—liver cancer	0.00164	0.002	CcSEcCtD
Exemestane—Erythema multiforme—Doxorubicin—liver cancer	0.00164	0.00199	CcSEcCtD
Exemestane—Cardiac disorder—Doxorubicin—liver cancer	0.00161	0.00196	CcSEcCtD
Exemestane—Back pain—Epirubicin—liver cancer	0.00158	0.00192	CcSEcCtD
Exemestane—Muscle spasms—Epirubicin—liver cancer	0.00157	0.00191	CcSEcCtD
Exemestane—Immune system disorder—Doxorubicin—liver cancer	0.00157	0.0019	CcSEcCtD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00155	0.01	CbGpPWpGaD
Exemestane—Alopecia—Doxorubicin—liver cancer	0.00154	0.00186	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—GSTA4—liver cancer	0.00153	0.00992	CbGpPWpGaD
Exemestane—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00153	0.0099	CbGpPWpGaD
Exemestane—Mental disorder—Doxorubicin—liver cancer	0.00152	0.00185	CcSEcCtD
Exemestane—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.00152	0.00981	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—GSTA4—liver cancer	0.00151	0.00979	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—GSTA2—liver cancer	0.00149	0.00967	CbGpPWpGaD
Exemestane—Malaise—Epirubicin—liver cancer	0.00147	0.00179	CcSEcCtD
Exemestane—Leukopenia—Epirubicin—liver cancer	0.00146	0.00178	CcSEcCtD
Exemestane—Back pain—Doxorubicin—liver cancer	0.00146	0.00178	CcSEcCtD
Exemestane—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.00146	0.00943	CbGpPWpGaD
Exemestane—Muscle spasms—Doxorubicin—liver cancer	0.00145	0.00176	CcSEcCtD
Exemestane—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.00145	0.00938	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—AHR—liver cancer	0.00145	0.00936	CbGpPWpGaD
Exemestane—CYP19A1—Ovarian Infertility Genes—CDKN1B—liver cancer	0.00144	0.00934	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—GSTA1—liver cancer	0.00144	0.00933	CbGpPWpGaD
Exemestane—Cough—Epirubicin—liver cancer	0.00143	0.00173	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—NAT2—liver cancer	0.00142	0.00922	CbGpPWpGaD
Exemestane—Hypertension—Epirubicin—liver cancer	0.00141	0.00171	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—NAT2—liver cancer	0.00141	0.0091	CbGpPWpGaD
Exemestane—Prednisone—ALB—liver cancer	0.0014	0.0653	CrCbGaD
Exemestane—Chest pain—Epirubicin—liver cancer	0.00139	0.00169	CcSEcCtD
Exemestane—Myalgia—Epirubicin—liver cancer	0.00139	0.00169	CcSEcCtD
Exemestane—Arthralgia—Epirubicin—liver cancer	0.00139	0.00169	CcSEcCtD
Exemestane—Anxiety—Epirubicin—liver cancer	0.00139	0.00168	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00138	0.00168	CcSEcCtD
Exemestane—Testosterone—CYP1A1—liver cancer	0.00137	0.0637	CrCbGaD
Exemestane—Malaise—Doxorubicin—liver cancer	0.00136	0.00166	CcSEcCtD
Exemestane—Leukopenia—Doxorubicin—liver cancer	0.00135	0.00164	CcSEcCtD
Exemestane—Confusional state—Epirubicin—liver cancer	0.00134	0.00163	CcSEcCtD
Exemestane—Oedema—Epirubicin—liver cancer	0.00133	0.00162	CcSEcCtD
Exemestane—Infection—Epirubicin—liver cancer	0.00133	0.00161	CcSEcCtD
Exemestane—Cough—Doxorubicin—liver cancer	0.00132	0.0016	CcSEcCtD
Exemestane—Nervous system disorder—Epirubicin—liver cancer	0.00131	0.00159	CcSEcCtD
Exemestane—Thrombocytopenia—Epirubicin—liver cancer	0.00131	0.00158	CcSEcCtD
Exemestane—Hypertension—Doxorubicin—liver cancer	0.00131	0.00158	CcSEcCtD
Exemestane—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.0013	0.00843	CbGpPWpGaD
Exemestane—Skin disorder—Epirubicin—liver cancer	0.0013	0.00157	CcSEcCtD
Exemestane—Hyperhidrosis—Epirubicin—liver cancer	0.00129	0.00156	CcSEcCtD
Exemestane—Arthralgia—Doxorubicin—liver cancer	0.00129	0.00156	CcSEcCtD
Exemestane—Chest pain—Doxorubicin—liver cancer	0.00129	0.00156	CcSEcCtD
Exemestane—Myalgia—Doxorubicin—liver cancer	0.00129	0.00156	CcSEcCtD
Exemestane—Anxiety—Doxorubicin—liver cancer	0.00128	0.00156	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00128	0.00155	CcSEcCtD
Exemestane—Anorexia—Epirubicin—liver cancer	0.00127	0.00154	CcSEcCtD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00126	0.00813	CbGpPWpGaD
Exemestane—Estrone—ALB—liver cancer	0.00125	0.0583	CrCbGaD
Exemestane—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.00125	0.00809	CbGpPWpGaD
Exemestane—Confusional state—Doxorubicin—liver cancer	0.00124	0.00151	CcSEcCtD
Exemestane—Oedema—Doxorubicin—liver cancer	0.00123	0.0015	CcSEcCtD
Exemestane—Infection—Doxorubicin—liver cancer	0.00123	0.00149	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00122	0.00147	CcSEcCtD
Exemestane—Nervous system disorder—Doxorubicin—liver cancer	0.00121	0.00147	CcSEcCtD
Exemestane—Thrombocytopenia—Doxorubicin—liver cancer	0.00121	0.00147	CcSEcCtD
Exemestane—Insomnia—Epirubicin—liver cancer	0.00121	0.00146	CcSEcCtD
Exemestane—Skin disorder—Doxorubicin—liver cancer	0.0012	0.00145	CcSEcCtD
Exemestane—Paraesthesia—Epirubicin—liver cancer	0.0012	0.00145	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—GPX3—liver cancer	0.00119	0.00774	CbGpPWpGaD
Exemestane—Hyperhidrosis—Doxorubicin—liver cancer	0.00119	0.00145	CcSEcCtD
Exemestane—Dyspnoea—Epirubicin—liver cancer	0.00119	0.00144	CcSEcCtD
Exemestane—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.00118	0.00767	CbGpPWpGaD
Exemestane—Anorexia—Doxorubicin—liver cancer	0.00118	0.00143	CcSEcCtD
Exemestane—Dyspepsia—Epirubicin—liver cancer	0.00117	0.00142	CcSEcCtD
Exemestane—Decreased appetite—Epirubicin—liver cancer	0.00116	0.00141	CcSEcCtD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00115	0.00748	CbGpPWpGaD
Exemestane—Gastrointestinal disorder—Epirubicin—liver cancer	0.00115	0.0014	CcSEcCtD
Exemestane—Fatigue—Epirubicin—liver cancer	0.00115	0.0014	CcSEcCtD
Exemestane—Pain—Epirubicin—liver cancer	0.00114	0.00138	CcSEcCtD
Exemestane—Constipation—Epirubicin—liver cancer	0.00114	0.00138	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—HPGDS—liver cancer	0.00114	0.00737	CbGpPWpGaD
Exemestane—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.00113	0.00734	CbGpPWpGaD
Exemestane—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00112	0.00136	CcSEcCtD
Exemestane—Insomnia—Doxorubicin—liver cancer	0.00112	0.00135	CcSEcCtD
Exemestane—Paraesthesia—Doxorubicin—liver cancer	0.00111	0.00134	CcSEcCtD
Exemestane—Dyspnoea—Doxorubicin—liver cancer	0.0011	0.00134	CcSEcCtD
Exemestane—Feeling abnormal—Epirubicin—liver cancer	0.0011	0.00133	CcSEcCtD
Exemestane—Gastrointestinal pain—Epirubicin—liver cancer	0.00109	0.00132	CcSEcCtD
Exemestane—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.00109	0.00705	CbGpPWpGaD
Exemestane—Dyspepsia—Doxorubicin—liver cancer	0.00109	0.00132	CcSEcCtD
Exemestane—Decreased appetite—Doxorubicin—liver cancer	0.00107	0.0013	CcSEcCtD
Exemestane—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00107	0.00129	CcSEcCtD
Exemestane—Fatigue—Doxorubicin—liver cancer	0.00106	0.00129	CcSEcCtD
Exemestane—Urticaria—Epirubicin—liver cancer	0.00106	0.00129	CcSEcCtD
Exemestane—Pain—Doxorubicin—liver cancer	0.00106	0.00128	CcSEcCtD
Exemestane—Constipation—Doxorubicin—liver cancer	0.00106	0.00128	CcSEcCtD
Exemestane—Body temperature increased—Epirubicin—liver cancer	0.00105	0.00128	CcSEcCtD
Exemestane—Abdominal pain—Epirubicin—liver cancer	0.00105	0.00128	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00105	0.00682	CbGpPWpGaD
Exemestane—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.00105	0.00678	CbGpPWpGaD
Exemestane—Feeling abnormal—Doxorubicin—liver cancer	0.00102	0.00123	CcSEcCtD
Exemestane—Gastrointestinal pain—Doxorubicin—liver cancer	0.00101	0.00122	CcSEcCtD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000991	0.00642	CbGpPWpGaD
Exemestane—Hypersensitivity—Epirubicin—liver cancer	0.000983	0.00119	CcSEcCtD
Exemestane—Urticaria—Doxorubicin—liver cancer	0.000981	0.00119	CcSEcCtD
Exemestane—Abdominal pain—Doxorubicin—liver cancer	0.000976	0.00118	CcSEcCtD
Exemestane—Body temperature increased—Doxorubicin—liver cancer	0.000976	0.00118	CcSEcCtD
Exemestane—Asthenia—Epirubicin—liver cancer	0.000957	0.00116	CcSEcCtD
Exemestane—Pruritus—Epirubicin—liver cancer	0.000944	0.00115	CcSEcCtD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000936	0.00606	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—CYP2E1—liver cancer	0.000928	0.00601	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—CYP2E1—liver cancer	0.000916	0.00593	CbGpPWpGaD
Exemestane—Diarrhoea—Epirubicin—liver cancer	0.000913	0.00111	CcSEcCtD
Exemestane—Hypersensitivity—Doxorubicin—liver cancer	0.000909	0.0011	CcSEcCtD
Exemestane—Asthenia—Doxorubicin—liver cancer	0.000886	0.00107	CcSEcCtD
Exemestane—Dizziness—Epirubicin—liver cancer	0.000882	0.00107	CcSEcCtD
Exemestane—CYP19A1—FSH signaling pathway—AKT1—liver cancer	0.000877	0.00568	CbGpPWpGaD
Exemestane—Pruritus—Doxorubicin—liver cancer	0.000873	0.00106	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—GGT1—liver cancer	0.000852	0.00552	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000851	0.00551	CbGpPWpGaD
Exemestane—Vomiting—Epirubicin—liver cancer	0.000848	0.00103	CcSEcCtD
Exemestane—Diarrhoea—Doxorubicin—liver cancer	0.000844	0.00102	CcSEcCtD
Exemestane—Rash—Epirubicin—liver cancer	0.000841	0.00102	CcSEcCtD
Exemestane—Dermatitis—Epirubicin—liver cancer	0.00084	0.00102	CcSEcCtD
Exemestane—Headache—Epirubicin—liver cancer	0.000836	0.00101	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—ABL1—liver cancer	0.000831	0.00538	CbGpPWpGaD
Exemestane—Dizziness—Doxorubicin—liver cancer	0.000816	0.00099	CcSEcCtD
Exemestane—Nausea—Epirubicin—liver cancer	0.000792	0.000962	CcSEcCtD
Exemestane—Vomiting—Doxorubicin—liver cancer	0.000785	0.000952	CcSEcCtD
Exemestane—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000778	0.00504	CbGpPWpGaD
Exemestane—Rash—Doxorubicin—liver cancer	0.000778	0.000944	CcSEcCtD
Exemestane—Dermatitis—Doxorubicin—liver cancer	0.000777	0.000944	CcSEcCtD
Exemestane—Headache—Doxorubicin—liver cancer	0.000773	0.000938	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—GSTP1—liver cancer	0.000766	0.00496	CbGpPWpGaD
Exemestane—Testosterone—ALB—liver cancer	0.000763	0.0355	CrCbGaD
Exemestane—CYP19A1—Metapathway biotransformation—GSTP1—liver cancer	0.000755	0.00489	CbGpPWpGaD
Exemestane—Nausea—Doxorubicin—liver cancer	0.000733	0.00089	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—GSTM1—liver cancer	0.000704	0.00456	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—GSTM1—liver cancer	0.000694	0.00449	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000679	0.00439	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—CYP1A1—liver cancer	0.000667	0.00432	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—CYP1A1—liver cancer	0.000658	0.00426	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000654	0.00424	CbGpPWpGaD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000651	0.00422	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000629	0.00407	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000621	0.00402	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—ESR1—liver cancer	0.000613	0.00397	CbGpPWpGaD
Exemestane—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000559	0.00362	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—BRAF—liver cancer	0.000545	0.00353	CbGpPWpGaD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000538	0.00349	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CDH1—liver cancer	0.000534	0.00345	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00051	0.0033	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.0005	0.00324	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—UGDH—liver cancer	0.000499	0.00323	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000497	0.00322	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000489	0.00317	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000482	0.00312	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—EPT1—liver cancer	0.000469	0.00304	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000452	0.00293	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000447	0.0029	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000446	0.00289	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—TAT—liver cancer	0.000445	0.00288	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MTOR—liver cancer	0.000444	0.00288	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000441	0.00286	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000437	0.00283	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000436	0.00282	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.00042	0.00272	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000416	0.00269	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.00041	0.00265	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CASP3—liver cancer	0.000409	0.00265	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CCND1—liver cancer	0.000398	0.00258	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—JUN—liver cancer	0.000397	0.00257	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—liver cancer	0.000394	0.00255	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000366	0.00237	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000349	0.00226	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—liver cancer	0.000347	0.00225	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000332	0.00215	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000327	0.00212	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MYC—liver cancer	0.000319	0.00207	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CPT1B—liver cancer	0.000302	0.00196	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GLUL—liver cancer	0.000302	0.00196	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—KRAS—liver cancer	0.000295	0.00191	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NR1H4—liver cancer	0.000291	0.00189	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTA3—liver cancer	0.000287	0.00186	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000271	0.00175	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000267	0.00173	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTA4—liver cancer	0.000262	0.0017	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—TP53—liver cancer	0.000262	0.0017	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000256	0.00166	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTA2—liver cancer	0.000255	0.00165	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000249	0.00161	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTA1—liver cancer	0.000246	0.0016	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NAT2—liver cancer	0.000244	0.00158	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000234	0.00152	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALDOB—liver cancer	0.000234	0.00151	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000223	0.00145	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CRABP1—liver cancer	0.000223	0.00144	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—AKT1—liver cancer	0.000221	0.00143	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.00022	0.00143	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000205	0.00133	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000203	0.00131	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000201	0.0013	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HPGDS—liver cancer	0.000195	0.00126	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000195	0.00126	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000194	0.00125	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000192	0.00124	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000176	0.00114	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000174	0.00113	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PSMA4—liver cancer	0.000174	0.00112	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PSMD10—liver cancer	0.000174	0.00112	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GOT2—liver cancer	0.000169	0.00109	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP2E1—liver cancer	0.000159	0.00103	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000154	0.000995	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYCS—liver cancer	0.000149	0.000962	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GGT1—liver cancer	0.000146	0.000944	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GOT1—liver cancer	0.000146	0.000944	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—UGDH—liver cancer	0.000146	0.000943	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—EPT1—liver cancer	0.000137	0.000886	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTP1—liver cancer	0.000131	0.000848	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TAT—liver cancer	0.00013	0.00084	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HMOX1—liver cancer	0.000129	0.000836	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTM1—liver cancer	0.00012	0.000779	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP1A1—liver cancer	0.000114	0.000739	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—MTHFR—liver cancer	0.000106	0.000689	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PPARA—liver cancer	0.000104	0.000675	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.37e-05	0.000607	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CG—liver cancer	8.94e-05	0.000578	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CPT1B—liver cancer	8.82e-05	0.000571	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GLUL—liver cancer	8.82e-05	0.000571	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PPARG—liver cancer	8.62e-05	0.000558	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NR1H4—liver cancer	8.51e-05	0.000551	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA3—liver cancer	8.36e-05	0.000541	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CD—liver cancer	7.85e-05	0.000509	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALB—liver cancer	7.75e-05	0.000502	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA4—liver cancer	7.65e-05	0.000495	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA2—liver cancer	7.45e-05	0.000483	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA1—liver cancer	7.19e-05	0.000466	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NAT2—liver cancer	7.11e-05	0.00046	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CB—liver cancer	6.85e-05	0.000443	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALDOB—liver cancer	6.82e-05	0.000441	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CRABP1—liver cancer	6.5e-05	0.000421	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HPGDS—liver cancer	5.68e-05	0.000368	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PSMA4—liver cancer	5.07e-05	0.000328	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PSMD10—liver cancer	5.07e-05	0.000328	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GOT2—liver cancer	4.93e-05	0.000319	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP2E1—liver cancer	4.63e-05	0.0003	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYCS—liver cancer	4.34e-05	0.000281	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GOT1—liver cancer	4.25e-05	0.000275	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GGT1—liver cancer	4.25e-05	0.000275	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CA—liver cancer	4.17e-05	0.00027	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTP1—liver cancer	3.82e-05	0.000247	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HMOX1—liver cancer	3.77e-05	0.000244	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTM1—liver cancer	3.51e-05	0.000227	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AKT1—liver cancer	3.41e-05	0.000221	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP1A1—liver cancer	3.33e-05	0.000216	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MTHFR—liver cancer	3.1e-05	0.000201	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PPARA—liver cancer	3.04e-05	0.000197	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CG—liver cancer	2.61e-05	0.000169	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PPARG—liver cancer	2.52e-05	0.000163	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CD—liver cancer	2.29e-05	0.000148	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALB—liver cancer	2.26e-05	0.000147	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CB—liver cancer	2e-05	0.000129	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CA—liver cancer	1.22e-05	7.89e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKT1—liver cancer	9.95e-06	6.44e-05	CbGpPWpGaD
